Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Rotavirus non-structural protein 6 (NSP6) is a small, basic protein encoded by an alternative, out-of-frame open reading frame (ORF) on genomic segment 11, which also encodes the essential NSP5 protein [1][2]. NSP6 is primarily localized within viroplasms, which are specialized cytoplasmic inclusion bodies where viral RNA replication and early particle morphogenesis take place [5]. Research indicates that NSP6 interacts directly with NSP5, a key regulator of viroplasm formation, suggesting that NSP6 may play a modulatory role in the viral replication cycle [3]. Interestingly, the NSP6 ORF is not universally conserved across all rotavirus strains; in some cases, it is truncated or absent, which implies it may be an accessory protein rather than an essential one for all viral lineages [4]. Despite its non-essential nature in some strains, it remains a subject of interest for understanding the complexity of rotavirus replication factories and as a potential niche target for antiviral intervention. Inhibiting NSP6 could theoretically destabilize the viroplasm environment, thereby reducing viral load during an active infection [3][5]. Currently, no clinical-stage drugs specifically target this protein, and its role as a therapeutic target remains largely exploratory in the context of broader rotavirus research.
There are currently no approved drugs that target NSP6; however, potential therapeutic strategies involve the disruption of NSP6-NSP5 protein interactions or the inhibition of NSP6 localization to viroplasms to prevent viral replication and assembly [3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Rotavirus non-structural protein 6 (NSP6).